Skip to Content

UK Edition. Click here for US version.

PIRITEZE ALLERGY 1MG/ML SYRUP

Active substance(s): CETIRIZINE HYDROCHLORIDE

PDF options:  View Fullscreen   Download PDF

PDF Transcript

Cetirizine Hydrochloride
Please read right through this leaflet before you start using this medicine.
This medicine is available without prescription, but you still need to use Piriteze Allergy Syrup
carefully to get the best results from it.
• Keep this leaflet, you may need to read it again.
• If you have any questions, or if there is anything you do not understand, ask your pharmacist.
In this leaflet:
1. What Piriteze Allergy Syrup does
2. Check before you take Piriteze Allergy Syrup
3. How to take Piriteze Allergy Syrup
4. Possible side effects
5. How to store Piriteze Allergy Syrup
6. Further information

1. What Piriteze Allergy Syrup does

Piriteze Allergy Syrup is used to treat the allergic symptoms of hayfever (itchy or watery eyes,
sneezing and a runny nose) and other allergies e.g. pet, house dust mite and mould spore allergies.
It can also be used to relieve the rashes and itching of chronic urticaria (hives).
The active ingredient is cetirizine hydrochloride, an antihistamine which can help to relieve the
symptoms of some allergies and itchy skin rashes.

2. Check before you take Piriteze Allergy Syrup
Do not take Piriteze Allergy Syrup:
• if you have ever had an allergic reaction to antihistamines or to any of the other ingredients (listed
in Section 6)
• if you have severe kidney problems

Take special care with Piriteze Allergy Syrup
• If you have an intolerance to some sugars, contact your doctor before taking this medicine.
• Be careful when drinking alcohol while using Piriteze Allergy Syrup. It can increase the effects of
drinking.
• Do not drive or operate machinery if the syrup makes you feel drowsy.
• If you have kidney problems as you may need to take a lower dose (see How to take Piriteze
Allergy Syrup).
• If you are epileptic or at risk of convulsions (fits).
• If you are having an allergy skin test you need to wait 3 days after taking Piriteze Allergy Syrup.
• If you have an enlarged prostate. It may increase the risk of having difficulty passing water.

If you are taking other medicines
Talk to your doctor or pharmacist before taking this syrup if you are taking any prescribed medicines;
including medicines obtained without a prescription.

Pregnancy and breast-feeding
Ask your doctor or pharmacist for advice before taking Piriteze Allergy Syrup if you are pregnant or
breast-feeding.
1 L639009/01 LNJP2
8N961C00

GlaxoSmithKline
Artwork Information Panel

Item Number:
8N961C00

GSK-ContractMfg-Eur-UK-France-Farmaclair-Herouville

Market or Pack Owner:

Market Trade Name:
Piriton Syrup

Colour Standard Reference Number:
N/A

Printing Process:
Offset

Substrate:
White Paper

CH-United Kingdom-GBR; CH-UK Regulatory-GBR

Technical Reference No(s).:
157x210-RS-100 Ed 2

(do NOT include the technical reference doc[s] version no[s].)

Manufacturing Site:

AIP_Disclaimers_INDD - NOV_2013 Version 2

8.0pt
8.25pt
100%
8.0pt
N

Total: 1

Special
Finishes

Colours

Varnishes

K

Total: 0

Total: 0

RSC A/W
Version:

4

Artwork copyright is the property of the GlaxoSmithKline Group of Companies
All suppliers providing a service to GSK for printed components of any description must ensure that they have a licence for all fonts / software used in conjunction with GSK artwork. The distribution and
use of fonts / software without a licence constitutes an intellectual property infringement. GSK will not accept any liability for the breach of third party intellectual property rights by printed component
suppliers. The GSK certification / audit process requires suppliers to declare that they do not use unlicensed fonts / software and may require the supplier to produce evidence of such licence to GSK.

To Ensure Accurate PDF Viewing and Printing:
FOR SCREEN VIEWING: Use Adobe Acrobat 7 Professional or Adobe Acrobat Reader, Standard or Professional (higher than 7).
Overprint Preview must be activated for accurate on screen viewing.
FOR PRINTING: Use only Acrobat Professional version 7 or higher. “Apply Overprint Preview” or “Simulate Overprinting” must be activated in the print settings for printing accurate hard copies.

180 mm Measuring Bar
If a status identification banner DOES NOT appear on this document, THEN this document has NOT been printed from the Global Pack Management system.

Page 1 of 2

3. How to take Piriteze Allergy Syrup
Pharma code Ref. No. 334

Adults and adolescents aged 12 years and over: Take two 5 ml spoonfuls once daily.
Children aged between 6 and 12 years: Give one 5 ml spoonful twice daily - morning
and evening.
Children under 6 years: Not recommended.
For people with moderate kidney problems: Take one 5 ml spoonful once daily.
• Do not take more than the recommended dose.
• Do not give to children under 6 years.
If you or a child take too much syrup
Contact your doctor or casualty department. Do not drive if you have taken too much.
If you forget to take the syrup
Take a dose as soon as you remember, unless it is nearly time to take the next one.
Never take two doses together.
If you stop taking the syrup:
• Rarely, pruritus (intense itching) and/or urticaria may occur. If your symptoms persist, see your
doctor.
• Seek medical advice if withdrawal symptoms are experienced.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, Piriteze Allergy Syrup can have side effects, but not everybody gets them.
Stop taking the medicine and seek immediate medical help if you experience:
• Sudden signs of an allergic reaction such as developing a rash, swelling of the mouth or face or
difficulty breathing
• Bruising or bleeding more easily than normal
• Convulsions or fits
• Loss of consciousness.
Stop taking the medicine and tell your doctor if you experience:
Confusion, hallucinations, abnormal liver function tests, rapid heartbeat.
The following side effects may occur:
Common: Headache or dizziness, drowsiness or tiredness, restlessness, dry mouth, sore throat,
abdominal pain, diarrhoea, nausea [feeling sick], runny nose.
Uncommon: Agitation, weakness, malaise, pins and needles, itching, rash or hives.
Rare: Aggression, depression, weight gain, swelling, insomnia, movement disorders including tremor,
muscle spasm and tics.
Very Rare: Taste disorder, blurred vision, eye movement disorder, difficult or painful or involuntary
urination.
At a very low frequency that cannot be estimated:
Increased appetite, memory loss, difficulty passing water or a feeling of dizziness.
In very rare cases people have had suicidal thoughts when taking this medicine. If you experience
these stop taking the medicine and see your doctor.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side
effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme
at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information
on the safety of this medicine.

5. How to store Piriteze Allergy Syrup

Keep out of the reach and sight of children.
Do not use this medicine after the 'EXP' date shown on the pack.

6. Further information

Active ingredient Each 5 ml dose contains Cetirizine Hydrochloride 5 mg.
Other ingredients Glycerol, propylene glycol, sorbitol (E 420), methyl parahydroxybenzoate (E 218),
propyl parahydroxybenzoate (E 216), sodium acetate, acetic acid, saccharin sodium, banana flavour
and purified water.
Methyl and propyl parahydroxybenzoates (E 218 and E 216) may cause allergic reactions (possibly delayed).
The bottle contains 70 ml.
The marketing authorisation holder is GlaxoSmithKline Consumer Healthcare (UK) Trading Limited,
Brentford, TW8 9GS, U.K. and all enquires should be sent to this address.
The manufacturer is Farmaclair, Avenue du General de Gaulle, 14200 Herouville Saint Clair, France.
This leaflet was last revised in December 2017.
Piriteze and the trigger device are registered trademarks owned by or licensed to the GSK group
of companies.
8N961C00

2

GlaxoSmithKline
Artwork Information Panel

Item Number:
8N961C00

GSK-ContractMfg-Eur-UK-France-Farmaclair-Herouville

Market or Pack Owner:

Market Trade Name:
Piriton Syrup

Colour Standard Reference Number:
N/A

Printing Process:
Offset

Substrate:
White Paper

CH-United Kingdom-GBR; CH-UK Regulatory-GBR

Technical Reference No(s).:
157x210-RS-100 Ed 2

(do NOT include the technical reference doc[s] version no[s].)

Manufacturing Site:

AIP_Disclaimers_INDD - NOV_2013 Version 2

8.0pt
8.25pt
100%
8.0pt
N

Total: 1

Special
Finishes

Colours

Varnishes

K

Total: 0

Total: 0

RSC A/W
Version:

4

Artwork copyright is the property of the GlaxoSmithKline Group of Companies
All suppliers providing a service to GSK for printed components of any description must ensure that they have a licence for all fonts / software used in conjunction with GSK artwork. The distribution and
use of fonts / software without a licence constitutes an intellectual property infringement. GSK will not accept any liability for the breach of third party intellectual property rights by printed component
suppliers. The GSK certification / audit process requires suppliers to declare that they do not use unlicensed fonts / software and may require the supplier to produce evidence of such licence to GSK.

To Ensure Accurate PDF Viewing and Printing:
FOR SCREEN VIEWING: Use Adobe Acrobat 7 Professional or Adobe Acrobat Reader, Standard or Professional (higher than 7).
Overprint Preview must be activated for accurate on screen viewing.
FOR PRINTING: Use only Acrobat Professional version 7 or higher. “Apply Overprint Preview” or “Simulate Overprinting” must be activated in the print settings for printing accurate hard copies.

180 mm Measuring Bar
If a status identification banner DOES NOT appear on this document, THEN this document has NOT been printed from the Global Pack Management system.

Page 2 of 2

+ Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide